CN111876879A - Antibacterial fabric and preparation method thereof - Google Patents
Antibacterial fabric and preparation method thereof Download PDFInfo
- Publication number
- CN111876879A CN111876879A CN202010759762.5A CN202010759762A CN111876879A CN 111876879 A CN111876879 A CN 111876879A CN 202010759762 A CN202010759762 A CN 202010759762A CN 111876879 A CN111876879 A CN 111876879A
- Authority
- CN
- China
- Prior art keywords
- weight
- parts
- fiber
- antibacterial
- spinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 95
- 239000004744 fabric Substances 0.000 title claims abstract description 48
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title description 3
- 239000000835 fiber Substances 0.000 claims abstract description 91
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 67
- 239000002131 composite material Substances 0.000 claims abstract description 38
- 238000009987 spinning Methods 0.000 claims abstract description 34
- 239000011787 zinc oxide Substances 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000001035 drying Methods 0.000 claims abstract description 18
- 238000003756 stirring Methods 0.000 claims abstract description 17
- 239000011259 mixed solution Substances 0.000 claims abstract description 16
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 13
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 13
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 13
- 239000011425 bamboo Substances 0.000 claims abstract description 13
- FWDBOZPQNFPOLF-UHFFFAOYSA-N ethenyl(triethoxy)silane Chemical compound CCO[Si](OCC)(OCC)C=C FWDBOZPQNFPOLF-UHFFFAOYSA-N 0.000 claims abstract description 13
- SJIXRGNQPBQWMK-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-methylprop-2-enoate Chemical compound CCN(CC)CCOC(=O)C(C)=C SJIXRGNQPBQWMK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 244000146553 Ceiba pentandra Species 0.000 claims abstract description 11
- 235000003301 Ceiba pentandra Nutrition 0.000 claims abstract description 11
- 229920002334 Spandex Polymers 0.000 claims abstract description 11
- 239000004759 spandex Substances 0.000 claims abstract description 11
- 238000010025 steaming Methods 0.000 claims abstract description 8
- 238000009941 weaving Methods 0.000 claims abstract description 8
- CHPZKNULDCNCBW-UHFFFAOYSA-N gallium nitrate Chemical compound [Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CHPZKNULDCNCBW-UHFFFAOYSA-N 0.000 claims description 47
- 108010010803 Gelatin Proteins 0.000 claims description 24
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 24
- 229920000159 gelatin Polymers 0.000 claims description 24
- 239000008273 gelatin Substances 0.000 claims description 24
- 235000019322 gelatine Nutrition 0.000 claims description 24
- 235000011852 gelatine desserts Nutrition 0.000 claims description 24
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 24
- 229940044658 gallium nitrate Drugs 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 20
- MMUFAGXJPKNAHT-UHFFFAOYSA-N copper;quinolin-8-ol Chemical compound [Cu].C1=CN=C2C(O)=CC=CC2=C1 MMUFAGXJPKNAHT-UHFFFAOYSA-N 0.000 claims description 16
- 241001330002 Bambuseae Species 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 8
- 238000007796 conventional method Methods 0.000 claims description 6
- IPCXNCATNBAPKW-UHFFFAOYSA-N zinc;hydrate Chemical compound O.[Zn] IPCXNCATNBAPKW-UHFFFAOYSA-N 0.000 claims description 2
- 241000588747 Klebsiella pneumoniae Species 0.000 abstract description 23
- 230000003385 bacteriostatic effect Effects 0.000 abstract description 6
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 19
- 239000000243 solution Substances 0.000 description 13
- 229910052742 iron Inorganic materials 0.000 description 12
- 238000009998 heat setting Methods 0.000 description 10
- 238000002166 wet spinning Methods 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- 230000015271 coagulation Effects 0.000 description 9
- 238000005345 coagulation Methods 0.000 description 9
- 239000008236 heating water Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 8
- -1 iron ions Chemical class 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 244000052616 bacterial pathogen Species 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 4
- 229960001296 zinc oxide Drugs 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 229910052733 gallium Inorganic materials 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000037488 Coccoloba pubescens Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 206010061259 Klebsiella infection Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000025584 Pericardial disease Diseases 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 208000002151 Pleural effusion Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000005757 colony formation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- IURRXCRWRKQLGC-UHFFFAOYSA-N copper;quinolin-8-ol Chemical compound [Cu].C1=CN=C2C(O)=CC=CC2=C1.C1=CN=C2C(O)=CC=CC2=C1 IURRXCRWRKQLGC-UHFFFAOYSA-N 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 230000009215 host defense mechanism Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 208000024356 pleural disease Diseases 0.000 description 1
- 206010035653 pneumoconiosis Diseases 0.000 description 1
- 229920006306 polyurethane fiber Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D15/00—Woven fabrics characterised by the material, structure or properties of the fibres, filaments, yarns, threads or other warp or weft elements used
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
- D01F1/103—Agents inhibiting growth of microorganisms
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/02—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from cellulose, cellulose derivatives, or proteins
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F8/00—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof
- D01F8/04—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers
- D01F8/10—Conjugated, i.e. bi- or multicomponent, artificial filaments or the like; Manufacture thereof from synthetic polymers with at least one other macromolecular compound obtained by reactions only involving carbon-to-carbon unsaturated bonds as constituent
-
- D—TEXTILES; PAPER
- D03—WEAVING
- D03D—WOVEN FABRICS; METHODS OF WEAVING; LOOMS
- D03D13/00—Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft
- D03D13/008—Woven fabrics characterised by the special disposition of the warp or weft threads, e.g. with curved weft threads, with discontinuous warp threads, with diagonal warp or weft characterised by weave density or surface weight
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
- D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
- D06M11/44—Oxides or hydroxides of elements of Groups 2 or 12 of the Periodic Table; Zincates; Cadmates
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/322—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen
- D06M13/372—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with compounds containing nitrogen containing etherified or esterified hydroxy groups ; Polyethers of low molecular weight
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
- D06M13/50—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment with organometallic compounds; with organic compounds containing boron, silicon, selenium or tellurium atoms
- D06M13/51—Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond
- D06M13/513—Compounds with at least one carbon-metal or carbon-boron, carbon-silicon, carbon-selenium, or carbon-tellurium bond with at least one carbon-silicon bond
- D06M13/5135—Unsaturated compounds containing silicon atoms
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M16/00—Biochemical treatment of fibres, threads, yarns, fabrics, or fibrous goods made from such materials, e.g. enzymatic
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/02—Natural fibres, other than mineral fibres
- D06M2101/04—Vegetal fibres
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/18—Synthetic fibres consisting of macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D06M2101/24—Polymers or copolymers of alkenylalcohols or esters thereof; Polymers or copolymers of alkenylethers, acetals or ketones
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2101/00—Chemical constitution of the fibres, threads, yarns, fabrics or fibrous goods made from such materials, to be treated
- D06M2101/16—Synthetic fibres, other than mineral fibres
- D06M2101/30—Synthetic polymers consisting of macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/25—Resistance to light or sun, i.e. protection of the textile itself as well as UV shielding materials or treatment compositions therefor; Anti-yellowing treatments
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
- D10B2201/01—Natural vegetable fibres
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2201/00—Cellulose-based fibres, e.g. vegetable fibres
- D10B2201/01—Natural vegetable fibres
- D10B2201/10—Bamboo
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2321/00—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds
- D10B2321/06—Fibres made from polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds polymers of unsaturated alcohols, e.g. polyvinyl alcohol, or of their acetals or ketals
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2331/00—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products
- D10B2331/10—Fibres made from polymers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polycondensation products polyurethanes
-
- D—TEXTILES; PAPER
- D10—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B—INDEXING SCHEME ASSOCIATED WITH SUBLASSES OF SECTION D, RELATING TO TEXTILES
- D10B2401/00—Physical properties
- D10B2401/13—Physical properties anti-allergenic or anti-bacterial
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Woven Fabrics (AREA)
- Multicomponent Fibers (AREA)
Abstract
The invention discloses an antibacterial fabric and a preparation method thereof. The preparation method of the antibacterial fabric comprises the following steps: placing 10-20 parts by weight of spandex, 20-30 parts by weight of kapok fiber, 30-40 parts by weight of bamboo fiber and 20-30 parts by weight of composite antibacterial fiber in a stirrer; then adding 6-10 parts by weight of diethylaminoethyl methacrylate, 2-6 parts by weight of vinyltriethoxysilane, 0.5-1.5 parts by weight of zinc oxide and 80-100 parts by weight of water, and stirring to obtain a mixed solution; drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling; and weaving the blended yarns into fabrics. The antibacterial fabric has good antibacterial performance, and particularly has a more prominent antibacterial and bacteriostatic effect on Klebsiella pneumoniae.
Description
Technical Field
The invention relates to a fabric and a preparation method thereof, in particular to an antibacterial fabric and a preparation method thereof.
Background
Microorganisms are closely related to people's daily life. On one hand, human beings use biotechnology to apply certain microorganisms to fermentation industry, biological pesticides and bacterial manure work; probiotics in the human body provide life-necessary substances or help the human body to absorb nutrients through metabolism. On the other hand, some microorganisms are pathogenic bacteria. The spread of pathogenic bacteria poses a great threat to human health and personal safety.
In recent years, people have higher and higher requirements on the comfort, health, safety, environmental protection and the like of garment materials, and have more and more requirements on the functions of safe and efficient antibacterial clothes; in life, people inevitably come into contact with various microorganisms such as bacteria and fungi, and the microorganisms can rapidly propagate under proper external conditions and spread diseases by means of contact and the like, so that the physical health and normal work, study and life of people are influenced. The fiber belongs to a porous material, and a multilayer body with countless gaps is formed after the fiber is overlapped and woven, so that the fabric can easily absorb bacteria. The antibacterial finishing is to make the fabric have the function of inhibiting the growth of bacteria, maintain the sanitary living environment of the clothes and ensure the health of human body. The use of antibacterial agents originated during world war ii when the German force had greatly reduced the bacterial infections of victims by wearing antibacterial military uniforms. In the last 60 th century, people mostly adopt organic antibacterial agents to produce antibacterial textiles; in the 21 st century, with the advent of the aging society, the number of bedridden people and home patients who are nursing at home has increased, and the demand for nursing articles for the elderly to prevent bedsores has also increased. Due to the change from the society with production as the main part to the concept with living as the main part, the development and research of products which are beneficial to the health of human bodies and the global environment, the antibacterial fabrics/fabrics are increasingly paid more attention by people. Therefore, the development of the fabric which is environment-friendly, safe and has excellent antibacterial performance is of great significance.
Klebsiella pneumoniae is the most important group of klebsiella pneumoniae of enterobacteriaceae (commonly known as pneumoconiosis), and has the scientific name: klebsiella Pneumoniae, the disease caused by which accounts for over 95% of Klebsiella infection.
It exists in the upper respiratory tract and intestinal tract of human body, and when the resistance of human body is reduced, it can enter into lung through respiratory tract to cause the fusion of large leaf and small leaf, and the above leaves are more common.
Klebsiella pneumoniae, the exudate from pathological changes is sticky and heavy, causing the space between the leaves to descend. The bacteria have a capsule and when growing and multiplying in the alveoli, cause tissue necrosis, liquefaction, and the formation of single or multiple abscesses. When the pleural and pericardial diseases are involved, exudative or purulent fluid accumulation may occur. The fibrous tissue of the focus is proliferated actively and is easy to organize; cellulosic pleural effusions can develop adhesions early. In hospital-infected septicemia, klebsiella is an important pathogen and the mortality rate is high.
CN107587252A provides a zinc oxide/gelatin/polyvinyl alcohol composite antibacterial fiber, which has good antibacterial effect on escherichia coli, staphylococcus aureus and bacillus subtilis, but is not ideal for klebsiella pneumoniae.
The antibacterial fiber and the antibacterial fabric in the prior art have very limited antibacterial effect on klebsiella pneumoniae, so that a textile with high-efficiency resistance to klebsiella pneumoniae needs to be further developed.
Disclosure of Invention
In order to achieve the purpose, the invention provides the antibacterial fabric which is good in Klebsiella pneumoniae antibacterial performance.
A preparation method of an antibacterial fabric comprises the following steps:
mixing spandex, kapok fiber, bamboo fiber and composite antibacterial fiber; then adding diethylaminoethyl methacrylate, vinyl triethoxysilane, zinc oxide and water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabrics.
Preferably, the first and second electrodes are formed of a metal,
a preparation method of an antibacterial fabric comprises the following steps:
placing 10-20 parts by weight of spandex, 20-30 parts by weight of kapok fiber, 30-40 parts by weight of bamboo fiber and 20-30 parts by weight of composite antibacterial fiber in a stirrer; then adding 6-10 parts by weight of diethylaminoethyl methacrylate, 2-6 parts by weight of vinyltriethoxysilane, 0.5-1.5 parts by weight of zinc oxide and 80-100 parts by weight of water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabrics.
The density of warp threads of the fabric is 80 threads/cm, and the density of weft threads of the fabric is 40 threads/cm.
Preferably, the first and second electrodes are formed of a metal,
the composite antibacterial fiber is prepared from gallium nitrate, zinc oxide, gelatin, polyvinyl alcohol and water by a conventional method.
The composite antibacterial fiber is prepared from 0.1-0.5 wt% of gallium nitrate, 0.5-2.0 wt% of zinc oxide, 2.0-3.0 wt% of gelatin, 10-20 wt% of polyvinyl alcohol and the balance of water by a conventional method.
The composite antibacterial fiber is prepared from 0.1-0.5 wt% of gallium nitrate, 0.5-1.5 wt% of 8-hydroxyquinoline copper, 0.5-2.0 wt% of zinc oxide, 2.0-3.0 wt% of gelatin, 10-20 wt% of polyvinyl alcohol and the balance of water by a conventional method.
The invention also provides a preparation method of the composite antibacterial fiber, which comprises the following steps: heating water to 65-75 ℃, adding gelatin and polyvinyl alcohol, mixing uniformly, adding gallium nitrate, zinc oxide and 8-hydroxyquinoline copper (if the formula is available), stirring and mixing uniformly, standing and defoaming to obtain a spinning stock solution;
wet spinning, drafting, drying and heat setting.
Preferably, the spinning solution is subjected to conventional wet spinning, the temperature of a coagulation bath is 45 ℃, and semi-finished fibers are obtained through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Although Klebsiella pneumoniae and Escherichia coli are both gram-negative bacteria, the antibacterial mechanism is not the same, and the antibacterial agent is not applicable.
Gallium nitrate belongs to an inorganic antibacterial agent, has the characteristics of the inorganic antibacterial agent, and has an antibacterial mechanism different from that of a common antibiotic. Pathogenic microorganisms typically grow attached to biofilms. The existence of the biological membrane can prevent the antibacterial drug from directly contacting with pathogenic bacteria, so that the drug can not exert the antibacterial effect. First, iron is essential for the growth and development of all pathogenic bacteria and is involved in DNA synthesis, oxidative stress defense mechanisms, ion transfer, and other processes. Second, many host defense mechanisms require iron ions, and iron deficiency can cause acute and chronic infections. In preventing acute infections, iron limitation is crucial and in many studies, over 18 different bacteria, increasing iron content can significantly reduce their resistance to acute infections. Studies have shown that high concentrations of iron are of great significance for early biofilm growth and colony formation during biofilm maturation (conversion to three-dimensional structures). Maintaining the iron concentration at a constant value may be protective during infection of the host by pathogenic bacteria. The iron chelator treatment experimental results show that certain organisms chelate iron with a chelator, gallium ions which cause secondary infection have ion radii similar to that of the iron ions, and the organisms may not distinguish the iron ions from the gallium ions, so that the gallium ions may have a competitive relationship with the iron ions and enter pathogenic bacteria in competition with iron, and the iron chelator treatment experimental results particularly effectively block metabolic processes involved by the iron ions against klebsiella pneumoniae, thereby showing antibacterial performance, while the blocking effect against escherichia coli is not obvious.
The 8-hydroxyquinoline copper belongs to a heterocyclic organic antibacterial agent with a benzo six-membered ring, is a typical chelate, is an excellent sterilizing, disinfecting and mildew-proof agent, and has toxicity: the oral administration of LD5015000mg/kg to mice is harmless to human and livestock, and the sterilization mechanism is systemic, osmotic and has good safety, and the traditional method is mainly used for preventing mildew of textiles. The antibacterial and bacteriostatic effects against escherichia coli and klebsiella pneumoniae are not reported.
Through research and analysis, the inventor firstly applies the 8-hydroxyquinoline copper to the antibacterial fiber for resisting and inhibiting bacteria of escherichia coli and klebsiella pneumoniae, and finds that the antibacterial fiber has obvious effect on resisting and inhibiting bacteria of klebsiella pneumoniae.
The zinc oxide has good ultraviolet shielding property and excellent antibacterial and bacteriostatic properties, and can endow the fabric with functions of sun protection, antibiosis, deodorization and the like when added into the fabric.
According to the invention, gallium nitrate, 8-hydroxyquinoline copper and zinc oxide are combined, an organic antibacterial agent and an inorganic antibacterial agent are combined, and the antibacterial effect of Klebsiella pneumoniae is synergistic.
The composite antibacterial fiber has good antibacterial performance, and particularly has more prominent antibacterial and bacteriostatic effects on Klebsiella pneumoniae.
The invention also discloses an antibacterial fabric which is prepared from the following raw materials of spandex, kapok fiber, bamboo fiber, composite antibacterial fiber, diethylaminoethyl methacrylate, vinyl triethoxysilane, 8-hydroxyquinoline copper and water by adopting a conventional method.
The invention also discloses an antibacterial fabric prepared by the method.
The antibacterial fabric has good antibacterial performance, and particularly has a more prominent antibacterial and bacteriostatic effect on Klebsiella pneumoniae.
Detailed Description
Zinc oxide: average particle size of 20 + -5 nm, Shanghai Allantin Biotechnology Co., Ltd;
gelatin: CAS number: 9000-70-8, Jiangsu Yuan Shengtong bioengineering Co., Ltd, a product number 1087 gelatin;
polyvinyl alcohol, CAS No.: 9002-89-5, and 088-50 parts of medium petrochemical great wall energy chemical PVA.
Gallium nitrate, english name: galliumnitrate, CAS No.: 13494-90-1.
Copper 8-hydroxyquinoline, english name: copperquinone, CAS No.: 10380-28-6.
In the examples and comparative examples, other parameters not specifically described were the same, thereby ensuring comparability between specific embodiments.
Spandex, polyurethane fiber, fiber length 50mm, fineness 2.4dtex, and organe chemical fiber warp and weft department of Zhu and City;
kapok fiber, with a fiber length of about 20mm, purchased from sanderian gmelin trade ltd;
bamboo fiber, the fiber length is about 38mm, the fiber fineness is 1.5D, and the bamboo fiber is purchased from Hangzhou Jiekang bamboo fiber products, Inc.;
diethylaminoethyl Methacrylate, 2-dimethyl Methacrylate, CAS: 105-16-8, EINECS: 203-275-7.
Vinyltriethoxysilane, Triethoxyvinylsilane, CAS: 78-08-0.
Example 1
A composite antibacterial fiber comprises the following raw materials: 0.1 wt% of gallium nitrate, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate and zinc oxide, uniformly stirring and mixing, standing and defoaming to obtain a spinning solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 2
A composite antibacterial fiber comprises the following raw materials: 0.3 wt% of gallium nitrate, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate and zinc oxide, uniformly stirring and mixing, standing and defoaming to obtain a spinning solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 3
A composite antibacterial fiber comprises the following raw materials: 0.5 wt% of gallium nitrate, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate and zinc oxide, uniformly stirring and mixing, standing and defoaming to obtain a spinning solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 4
A composite antibacterial fiber comprises the following raw materials: 0.1 wt% of gallium nitrate, 1.2 wt% of 8-hydroxyquinoline copper, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate, zinc oxide and 8-hydroxyquinoline copper, uniformly stirring and mixing, standing and defoaming to obtain a spinning stock solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 5
A composite antibacterial fiber comprises the following raw materials: 0.3 wt% of gallium nitrate, 1.0 wt% of 8-hydroxyquinoline copper, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate, zinc oxide and 8-hydroxyquinoline copper, uniformly stirring and mixing, standing and defoaming to obtain a spinning stock solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 6
A composite antibacterial fiber comprises the following raw materials: 0.5 wt% of gallium nitrate, 0.8 wt% of 8-hydroxyquinoline copper, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate, zinc oxide and 8-hydroxyquinoline copper, uniformly stirring and mixing, standing and defoaming to obtain a spinning stock solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Example 7
A composite antibacterial fiber comprises the following raw materials: 1.3 wt% of gallium nitrate, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding gallium nitrate and zinc oxide, uniformly stirring and mixing, standing and defoaming to obtain a spinning solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
Escherichia coli ATCC11229 and Klebsiella pneumoniae ATCC4352 have 69.3% and 87.5% respectively.
Example 8
A composite antibacterial fiber comprises the following raw materials: 1.3 wt% of 8-hydroxyquinoline copper, 1.3 wt% of zinc oxide, 2.5 wt% of gelatin, 18 wt% of polyvinyl alcohol and the balance of water.
Heating water to 70 ℃, adding gelatin and polyvinyl alcohol, uniformly mixing, adding zinc oxide and 8-hydroxyquinoline copper, uniformly stirring and mixing, standing and defoaming to obtain a spinning stock solution;
wet spinning the spinning solution at a coagulation bath temperature of 45 ℃ to obtain semi-finished fibers through drafting, drying and heat setting; and then the semi-finished fiber is washed, dried and cut to prepare the composite antibacterial fiber.
The bacteriostasis rate of escherichia coli ATCC11229 is 53.8%, and the bacteriostasis rate of Klebsiella pneumoniae ATCC4352 is 65.1%.
Test example 1
The national standard GB/T20994.3-2008' evaluation part 3 of antibacterial performance of textiles: the vibration method carries out antibacterial property quantitative test on the composite antibacterial fiber, tests the antibacterial rate of the fiber without washing, and samples: 0.75 g of composite antibacterial fiber, strain: coli ATCC11229, klebsiella pneumoniae ATCC 4352. The test results are shown in Table 1.
Table 1: composite antibacterial fiber bacteriostasis rate test meter (%)
The composite antibacterial fiber has good antibacterial performance, and particularly has more prominent antibacterial and bacteriostatic effects on Klebsiella pneumoniae.
Example 9
The preparation method of the antibacterial fabric comprises the following steps:
placing 15 parts by weight of spandex, 25 parts by weight of kapok fiber, 35 parts by weight of bamboo fiber and 25 parts by weight of the composite antibacterial fiber of example 5 in a stirrer; then adding 8 parts by weight of diethylaminoethyl methacrylate, 4 parts by weight of vinyltriethoxysilane, 1 part by weight of zinc oxide and 90 parts by weight of water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabric, wherein the warp density of the fabric is 80 pieces/cm, and the weft density of the fabric is 40 pieces/cm.
Example 10
The preparation method of the antibacterial fabric comprises the following steps:
placing 15 parts by weight of spandex, 25 parts by weight of kapok fiber, 35 parts by weight of bamboo fiber and 25 parts by weight of the composite antibacterial fiber of example 7 in a stirrer; then adding 8 parts by weight of diethylaminoethyl methacrylate, 4 parts by weight of vinyltriethoxysilane, 1 part by weight of zinc oxide and 90 parts by weight of water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabric, wherein the warp density of the fabric is 80 pieces/cm, and the weft density of the fabric is 40 pieces/cm.
Example 11
The preparation method of the antibacterial fabric comprises the following steps:
placing 15 parts by weight of spandex, 25 parts by weight of kapok fiber, 35 parts by weight of bamboo fiber and 25 parts by weight of the composite antibacterial fiber of example 8 in a stirrer; then adding 8 parts by weight of diethylaminoethyl methacrylate, 4 parts by weight of vinyltriethoxysilane, 1 part by weight of zinc oxide and 90 parts by weight of water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabric, wherein the warp density of the fabric is 80 pieces/cm, and the weft density of the fabric is 40 pieces/cm.
Test example 2
The national standard GB/T20994.3-2008' evaluation part 3 of antibacterial performance of textiles: the oscillating method carries out quantitative antibacterial test on the antibacterial fabric, tests the antibacterial rate after washing for 10 times, and samples: 0.75 g of antibacterial fabric, strain: coli ATCC11229, klebsiella pneumoniae ATCC 4352.
Table 2: antibacterial fabric bacteriostasis rate test meter (%)
| Escherichia coli ATCC11229 | Klebsiella pneumoniae ATCC4352 | |
| Example 9 | 45.3 | 77.8 |
| Example 10 | 56.5 | 73.2 |
| Example 11 | 42.6 | 65.5 |
Claims (5)
1. The preparation method of the antibacterial fabric is characterized by comprising the following steps:
mixing spandex, kapok fiber, bamboo fiber and composite antibacterial fiber; then adding diethylaminoethyl methacrylate, vinyl triethoxysilane, zinc oxide and water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabrics.
2. The method for preparing the antibacterial fabric according to claim 1, characterized by comprising the following steps:
placing 10-20 parts by weight of spandex, 20-30 parts by weight of kapok fiber, 30-40 parts by weight of bamboo fiber and 20-30 parts by weight of composite antibacterial fiber in a stirrer; then adding 6-10 parts by weight of diethylaminoethyl methacrylate, 2-6 parts by weight of vinyltriethoxysilane, 0.5-1.5 parts by weight of zinc oxide and 80-100 parts by weight of water, and stirring to obtain a mixed solution;
drying the mixed solution, and preparing blended spinning yarn after roving, spinning, automatic spooling, yarn steaming and doubling;
and weaving the blended yarns into fabrics.
3. The method for preparing the antibacterial fabric according to claim 2, wherein the composite antibacterial fiber is prepared from the raw materials of gallium nitrate, zinc oxide, gelatin, polyvinyl alcohol and water by a conventional method.
4. An antibacterial fabric is prepared from spandex, kapok fiber, bamboo fiber, composite antibacterial fiber, diethylaminoethyl methacrylate, vinyltriethoxysilane, 8-hydroxyquinoline copper and water by a conventional method.
5. An antibacterial fabric prepared by the method of claim 1, 2 or 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010759762.5A CN111876879A (en) | 2020-07-31 | 2020-07-31 | Antibacterial fabric and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010759762.5A CN111876879A (en) | 2020-07-31 | 2020-07-31 | Antibacterial fabric and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111876879A true CN111876879A (en) | 2020-11-03 |
Family
ID=73205889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010759762.5A Pending CN111876879A (en) | 2020-07-31 | 2020-07-31 | Antibacterial fabric and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111876879A (en) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2682745A1 (en) * | 2007-04-02 | 2009-01-15 | Sideromics, Llc | Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds |
| CN101374532A (en) * | 2006-01-30 | 2009-02-25 | 泰坦医药品公司 | Use of gallium to treat biofilm-associated infectons |
| WO2009121183A1 (en) * | 2008-04-03 | 2009-10-08 | Kane Biotech Inc. | Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof |
| CN102700211A (en) * | 2012-06-19 | 2012-10-03 | 常州市天润木业有限公司 | Antibacterial and mould-proof compact grade laminate and preparation method of antibacterial and mould-proof compact grade laminate |
| CN104473962A (en) * | 2005-11-01 | 2015-04-01 | 西奈山医学院(美国) | Growth control of oral and superficial microorganisms using gallium compounds |
| CN104884545A (en) * | 2012-10-29 | 2015-09-02 | 阿里斯特医疗公司 | Polymer coating compositions and coated products |
| CN107475857A (en) * | 2017-09-14 | 2017-12-15 | 储旭 | A kind of antibiotic facing material and preparation method thereof |
| CN107587252A (en) * | 2017-09-14 | 2018-01-16 | 储旭 | A kind of antibacterial socks not easy to fade and preparation method thereof |
| CN109206570A (en) * | 2017-06-30 | 2019-01-15 | 翁秋梅 | A kind of compliant physical split-phase supermolecule dynamic aggregation object and its application |
| CN109629073A (en) * | 2018-12-07 | 2019-04-16 | 北京富乐喜科技有限公司 | A method of antimicrobial form fiber cloth is prepared using fullerene |
-
2020
- 2020-07-31 CN CN202010759762.5A patent/CN111876879A/en active Pending
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104473962A (en) * | 2005-11-01 | 2015-04-01 | 西奈山医学院(美国) | Growth control of oral and superficial microorganisms using gallium compounds |
| CN101374532A (en) * | 2006-01-30 | 2009-02-25 | 泰坦医药品公司 | Use of gallium to treat biofilm-associated infectons |
| CA2682745A1 (en) * | 2007-04-02 | 2009-01-15 | Sideromics, Llc | Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds |
| WO2009121183A1 (en) * | 2008-04-03 | 2009-10-08 | Kane Biotech Inc. | Dispersinbtm, 5-fluorouracil, deoxyribonuclease i and proteinase k-based antibiofilm compositions and uses thereof |
| CN102700211A (en) * | 2012-06-19 | 2012-10-03 | 常州市天润木业有限公司 | Antibacterial and mould-proof compact grade laminate and preparation method of antibacterial and mould-proof compact grade laminate |
| CN104884545A (en) * | 2012-10-29 | 2015-09-02 | 阿里斯特医疗公司 | Polymer coating compositions and coated products |
| CN109206570A (en) * | 2017-06-30 | 2019-01-15 | 翁秋梅 | A kind of compliant physical split-phase supermolecule dynamic aggregation object and its application |
| CN107475857A (en) * | 2017-09-14 | 2017-12-15 | 储旭 | A kind of antibiotic facing material and preparation method thereof |
| CN107587252A (en) * | 2017-09-14 | 2018-01-16 | 储旭 | A kind of antibacterial socks not easy to fade and preparation method thereof |
| CN109629073A (en) * | 2018-12-07 | 2019-04-16 | 北京富乐喜科技有限公司 | A method of antimicrobial form fiber cloth is prepared using fullerene |
Non-Patent Citations (1)
| Title |
|---|
| 化工百科全书》编辑委员会等: "《化工百科全书 第17卷 无机聚合物—心血管疾病药物》", 30 April 1998, 化学工业出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1490543B1 (en) | Antimicrobial yarn having nanosilver particles and methods for manufacturing the same | |
| WO2006066488A1 (en) | Manufacturing methods and applications of antimicrobial plant fibers having silver particles | |
| Mirjalili et al. | Antibacterial dyeing of polyamide using turmeric as a natural dye | |
| AU2011240856B2 (en) | Antimicrobial treatment of synthetic nonwoven textiles | |
| US20150140219A1 (en) | Disinfectant composition for textile and related substrates, and method of treating a substrate to provide disinfecting antibacterial, antiviral and antifungal, wash durable, optionally enhanced with multifunctional properties | |
| CN107475857A (en) | A kind of antibiotic facing material and preparation method thereof | |
| US20080102217A1 (en) | Process for anti-microbial textiles treatment | |
| CN108621481B (en) | Antibacterial fabric containing silver ions and antibacterial textile | |
| US20170167073A1 (en) | Antimicrobial textiles and methods for production of the same | |
| CN116867940A (en) | Antimicrobial and antiviral nanocomposite sheet | |
| CN107675292B (en) | A kind of nano-silver bamboo charcoal fiber and its Bactericidal underwear product | |
| CN108265360A (en) | A kind of antimicrobial yarn | |
| WO2021253015A1 (en) | Textile treatment compositions | |
| CN111876879A (en) | Antibacterial fabric and preparation method thereof | |
| Khude et al. | Development of antibacterial knitted fabrics from polyester-silver nanocomposite fibres | |
| Kut et al. | Effects of Environmental Conditions on the Antibacterial Activity of Treated Cotton Knits. | |
| Condò et al. | Antimicrobial activity of silver doped fabrics for the production of hospital uniforms | |
| CN111719196A (en) | Composite antibacterial fiber and preparation method thereof | |
| CN102102240A (en) | Antibacterial polyester fibers and manufacturing method and application thereof | |
| CN114438778A (en) | Antistatic, antibacterial and deodorant fabric and preparation method thereof | |
| CN216139549U (en) | Antibacterial and antiviral fabric and medical protective clothing | |
| Majchrzycka et al. | Aspects of tests and assessment of filtering materials used for respiratory protection against bioaerosols. Part I: Type of active substance, contact time, microorganism species | |
| CN107604651A (en) | A kind of negative ion health fabric and its soaking agent and application | |
| Murugesan | Characterization of Antimicrobial Finished Flame-Retardant Textile Materials | |
| Utku et al. | Use of Ag-TiO2 and ZnPT Complexes in the Development of Antimicrobial Textiles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201103 |